Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
30
31
1
2
4
5
6
7
8
10
11
12
12:00 AM - PFF Summit 2015
13
14
15
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
6
NextEdge Health Experience Summit
2015-11-03 - 2015-11-04    
All Day
With a remarkable array of speakers and panelists, the Next Edge: Health Experience Summit is shaping-up to be an event that attracts healthcare professionals who [...]
mHealthSummit 2015
2015-11-08 - 2015-11-11    
All Day
Anytime, Anywhere: Engaging Patients and ProvidersThe 7th annual mHealth Summit, which is now part of the HIMSS Connected Health Conference, puts new emphasis on innovation [...]
24th Annual Healthcare Conference
2015-11-09 - 2015-11-11    
All Day
The Credit Suisse Healthcare team is delighted to invite you to the 2015 Healthcare Conference that takes place November 9th-11th in Arizona. We have over [...]
PFF Summit 2015
2015-11-12 - 2015-11-14    
All Day
PFF Summit 2015 will be held at the JW Marriott in Washington, DC. Presented by Pulmonary Fibrosis Foundation Visit the www.pffsummit.org website often for all [...]
2nd International Conference on Gynecology & Obstetrics
2015-11-16 - 2015-11-18    
All Day
Welcome Message OMICS Group is esteemed to invite you to join the 2nd International conference on Gynecology and Obstetrics which will be held from November [...]
Events on 2015-11-03
NextEdge Health Experience Summit
3 Nov 15
Philadelphia
Events on 2015-11-08
mHealthSummit 2015
8 Nov 15
National Harbor
Events on 2015-11-09
Events on 2015-11-12
PFF Summit 2015
12 Nov 15
Washington, DC
Events on 2015-11-16
Latest News

Global Cancer Tumor Profiling Market Key Vendors, Drivers and Forecast 2024

According to the study, Cancer is proving the most fatal disease nowadays; therefor profiling cancer is in the great demand with seamlessly integrating next-generation sequencing (NGS) and in-situ hybridization for cancer profiling. In addition, cancer profiling for the detection of molecular & genetic level of cancers, and use of personalized and targeted approaches for treatment have propelled the market growth.

The Global Cancer Tumor Profiling Market  accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024.

The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The potential of cancer profiling is extended from common cancers such as lymphoma and breast cancer to molecular profiling of lung cancer, prostate cancer and acute leukemia.

No. of Report Pages: 350

Request for Free Sample of Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-tumor-profiling-market

Major Market Drivers and Restraints:

  • Technological advancements for identifying the cancer tumors.
  • Increasing the cancer incidences.
  • Increase in the use of biomarkers in tumor profiling.
  • Availability of Funding for Cancer Research
  • Increase in demand for next generation sequencing technique in cancer profiling.
  • Lack of Skilled Professionals and Infrastructure
  • Growth in demand of personalized medicines

Browse Full Detailed with TOC, Sample, Inquiry, Expert and Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/reports/global-cancer-tumor-profiling-market/

Market Segmentation by Types

By Technique the market is segmented in

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

By Application the market is segmented into

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research applications

On the basis of geography, global cancer tumor profiling market report covers data points for 28 countries across multiple geographies such as

  • North America & South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Top Key Players are:

tareIllumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp., NanoString Technologies, Inc., Oxford Gene Technology, Abbott, BD, Hologic, Inc., Siemens Medical Solutions USA, Inc., Personal Genome Diagnostics, Inc., FOUNDATION MEDICINE, INC., Contextual Genomics, AGENDIA, Perthera, Inc., ApoCell, GenScript, Ribomed, Boreal Genomics Inc., Biotheranostics and Proteome Sciences among others.

For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-tumor-profiling-market

Related Report  

Global Computed Tomography Devices Market – Industry Trends and Forecast to 2024

Global Computed Tomography Devices Market, By product (Low Slice CT Scanner, Medium Slice CT Scanner, High Slice CT Scanner), by Application (Cardiovascular, Oncology, Neurovascular, Abdomen and Pelvic, Pulmonary Angiogram, Spinal, Musculoskeletal), by End-User (Hospitals, Diagnostics Centers), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Access Report: http://databridgemarketresearch.com/reports/global-computed-tomography-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research